Advanced searches left 3/3

A1C - Europe PMC

Summarized by Plex Scholar
Last Updated: 10 May 2022

* If you want to update the article please login/register

Hemoglobin A1c, hemoglobin glycation index, and triglyceride and glucose index: Useful tools to predict low feed intake associated with glucose intolerance in lactating sows.

The purpose of the present study was to assess hemoglobin A1c, the hemoglobin glycation index, and triglyceride and glucose index as predictive indicators of low feeding intake in lactating sows due to glucose intolerance. On day 3 of lactation, the highest blood glucose level was seen. On farrowing day and day 21 of lactation, the average glycemic concentrations obtained from HbA1c were lower than those measured by a glucometer on the same days. According to the TG index obtained from a glucometer, 83. 0% of sows were glucose intolerant, relative to 100% at farrowing. When the TG index was calculated using the HGI, half of G2 did not display glucose intolerance when the TG index was calculated using the HGI, relative to 54% when it was determined using blood glucose measurements determined by a glucometer.

Source link: https://europepmc.org/article/MED/35511787


Comparison of Collaborative Goal Setting With Enhanced Education for Managing Diabetes-Associated Distress and Hemoglobin A1c Levels: A Randomized Clinical Trial.

Importance Type 2 diabetes is a common and morbid disease. Poor self-management can lead to diabetes-associated anxiety and delay diabetes control. Following the intervention and after 6-month maintenance, Empowering Patients in Chronic Care, an evidence-based solution to reduce diabetes-associated anxiety and hemoglobin A1c levels, was evaluated and evaluated by the end. From July 1, 2015 to June 30, 2017, this hybrid randomized clinical trial was conducted in Veterans Affairs clinics throughout Illinois, Indiana, and Texas. This hybrid randomized clinical trial was conducted in Veterans Affairs clinics across Illinois, Indiana, and Texas. Participants included adults with uncontrolled type 2 diabetes who received primary care in participating clinics during the previous year. Participation in EPICC 6 group sessions based on a team goal-setting model based on a collaborative goal-setting approach led by health care professionals. Results A total of 280 people with type 2 diabetes were equally allocated to EPICC or EUC. Comparing to EUC, participants in EPICC saw dramatic post-intervention improvements in HbA1c levels and DDS. During maintenance, differences between the EUC and EPICC groups remained significant for DDS score, but not for HbA1c values. In changes involving either adherence or self-efficacy, there were no gaps between EPICC and EUC. The EPICC group members attended a total of 4. 34 sessions, with 54 of them receiving all six sessions. Conclusions and relevance In primary care, the patient-empowerment strategy employing longitudinal collaborative goal setting and motivational interviewing is feasible. After the intervention were not successful after maintenance, HbA1c levels increased dramatically.

Source link: https://europepmc.org/article/MED/35507345


The relationship between Hemoglobin A1c and the maximal plaque stress of culprit ruptured plaques in patients with ST-segment elevated myocardial infarction.

Plaque structural stress has been used to measure the likelihood of plaque rupture. However, the exact causes influencing factors that influence plaque structural stress in ST-segment accelerated myocardial infarction patients with ruptured plaques are uncertain. Methods We investigated the plaque structure and estimated the maximum plaque stress of the culprit lesions in 162 patients with plaque rupture by performing finite element analysis, based on optical coherence tomography. Hemoglobin A1c was significantly higher in the high stress group than in the low stress group, according to the researchers. Patients with diabetes had a significantly higher incidence of maximal plaque pressure than those without diabetes. Conclusions of OCT-based finite-element analysis revealed that HbA1c was positively linked to the severity of maximal plaque inflammation in STEMI patients with plaque rupture, raising the importance of glucose monitoring in patients with coronary atherosclerotic disease.

Source link: https://europepmc.org/article/MED/35490785


Diagnostic Accuracy of Salivary Biomarkers including Lactate Dehydrogenase and Hemoglobin A1c for Screening Chronic Periodontitis.

Periodontitis is one of the most common persistent bacterial infections in humans involving the tooth-support tissue. Aims : Periodonitis is one of the most common chronic bacterial infections related to the tooth-support tissue. The current research was designed to identify and compare salivary biomarkers, including lactate dehydrogenase and hemoglobin A1c, in patients with severe chronic periodontitis and healthy individuals. Methods : This research was conducted on 29 patients with chronic periodontitis and 30 healthy people at Zahedan University of Medical Sciences, Zahedan, Iran, in 2021. Chronic periodontitis disease diagnostic tests were performed on HbA1c and LDH's sensitivity, specificity, and positive and negative predictive values.

Source link: https://europepmc.org/article/MED/35521636


Association between liver and chronic kidney disease on hemoglobin A1c concentrations.

Introduction HbA1c is the gold standard for measuring long-term glycemic control in patients with type-2 diabetes mellitus. Compared to over 21,000 test findings without LD, iron deficiency anemia, or CKD, we reviewed more than 2,500 test findings with LD and 20,000 with CKD. Patients were classified as having LD if they had high ALT and AST concentrations and classed as CKD, if they had elevated serum creatinine and BUN abnormalities, or low eGFR based on age-based reference ranges. Results The median HbA1c concentration in both males and females was 5. 8% vs. 5. 4% for females and 5. 6% for males without LD. A significant difference in median HbA1c concentrations was also observed between CKD samples and non-CKD samples. HbA1c concentrations may have increased AST and ALT concentrations in patients with elevated AST and ALT levels or CKD.

Source link: https://europepmc.org/article/MED/35447144


Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study.

Background diabetes mellitus raises the risk of having hypertension. The connection between glycosylated hemoglobin A1c level and incident hypertension remains unclear. This report looked at the relationship between the baseline level and rise in the HbA1c level in non-diabetic individuals over three years. Methods This community-based cohort study was conducted with 2591 people aged 40-75 years without hypertension or diabetes at baseline who participated in a longitudinal research program. HbA1c change in the fully adjusted linear regression models remained significant in terms of rises in systolic blood pressure and diastolic blood pressure [-coefficient, 4. 421, 1. 681]. Conclusions A elevated baseline HbA1c level was not a risk factor for event hypertension, according to experts, but HbA1c elevations were not directly related to a rise in blood pressure and an elevated risk of incident hypertension in non-diabetic individuals.

Source link: https://europepmc.org/article/MED/35436969


Impact of Glucagon-Like Peptide 1 Receptor Agonists in Patients with Hemoglobin A1c of 9% or Greater.

Objectives After inserting a GLP-1 agonist in patients with a baseline HbA1c of 9% or greater, this study was designed to assess glycemic control and weight loss. Methods A single-health system retrospective chart review identified adults with type 2 diabetes mellitus with a baseline hemoglobin A1c of 9% or higher and were given a GLP-1 agonist for eligibility. HbA1c from baseline to the first HbA1c test was the primary outcome measured. The mean change in HbA1c from baseline to first HbA1c test for all participants was -2. 1%. The mean change in weight from baseline to first HbA1c check was -2. 0 kgs. Conclusion In patients with type 2 diabetes mellitus with a baseline HbA1c 9%, GLP-1 agonist initiation resulted in a significant decrease in both HbA1c and weight relative to baseline, which is notably smaller than baseline.

Source link: https://europepmc.org/article/MED/35427194


Late non-fasting plasma glucose predicts cardiovascular mortality independent of hemoglobin A1c

It is unknown if non-fasting plasma glucose is related to cardiovascular disease mortality. To determine hazard ratios and 95% confidence intervals of PG for CVD mortality, Cox proportional hazards models were used. Higher late non-fasting PG was correlated with higher CVD mortality risks. In addition, at the cut-off of 115 mg/dL, higher late non-fasting PG was associated with increased CVD mortality risks in those with either a normal or prediabetic HbA1c level. A late non-fasting PG with a cut-off of 115 mg/dL may be used to identify individuals at high risk of CVD.

Source link: https://europepmc.org/article/PPR/PPR480343

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions